Peptilogics
Peptilogics is a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections. The company's lead candidate, zaloganan (PLG0206), is an investigational treatment for prosthetic joint infections currently in clinical development.
Leadership & Board
- Current Number of Employees
- 22
- Current LinkedIn Followers
- 4,482
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $78M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $78M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Company Momentum Positive
Peptilogics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Peptilogics had 22 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Peptilogics had 4,482 followers as of October 12, 2026. The number of followers increased by 14 (0.31%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 16, 2025 | Series B | $78.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Founders Fund | Series B |
| AMR Action Fund | Series B |
| Narya Capital | Series B |
| Presight Capital | Series B |
| Thiel Bio | Series B |
| Beyond Ventures | Series B |
Similar Companies
A snapshot of private companies similar to Peptilogics, helping you discover and navigate related company profiles.
Related News and Analysis
